

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 61.10 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 82.64 | Oscillator | Sell |
| Williams %R (14) | -9.75 | Oscillator | Sell |
| MACD (12, 26, 9) | 0.03 (Hist 0.29) | Oscillator | Strong Buy |
| Average Directional Index (14) | 20.06 (+DI 20.6 / -DI 23.0) | Trend | Sell |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 15, 26 | Hernandez David Christopher | director: | 0 | — | |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
| EMA 20 | 33.31 | MA | Strong Buy |
| SMA 20 | 32.76 | MA | Strong Buy |
| EMA 50 | 33.75 | MA | Strong Buy |
| SMA 50 | 34.17 | MA | Buy |
| SMA 200 | 35.76 | MA | Sell |
| Sep 30, 26 |
| Smith Maurice S |
| director |
| A-Award |
| 1,162 |
| — |
| Aug 31, 26 | Carre Eric | officer: EVP & Chief Financial Officer | S-Sale | 24,777 @ $37.50 | $929.1K |
| Aug 19, 26 | Slocum Jeffrey Shannon | director, officer: Director, EVP and COO | S-Sale | 52,572 @ $35.09 | $1.84M |
| Aug 18, 26 | Slocum Jeffrey Shannon | director, officer: Director, EVP and COO | S-Sale | 16,121 @ $35.08 | $565.6K |
| Aug 18, 26 | Miller Jeffrey Allen | director, officer: Director, President & CEO | S-Sale | 124,483 @ $35.00 | $4.36M |
| Jun 30, 26 | Smith Maurice S | director | A-Award | 1,080 | — |
| Jun 18, 26 | Carre Eric | officer: EVP & Chief Financial Officer | S-Sale | 24,778 @ $35.89 | $889.3K |
Stock news · updated daily
Wall Street analysts are reshuffling their bets on Tesla, Netflix, and Dutch Bros while SpaceX's blowout earnings send futures sliding ahead of the open. Find out which names got upgraded, downgraded, or initiated before the market moves on Thursday.
Halliburton (NYSE: HAL) reported third-quarter 2026 revenue of $5.7 billion and adjusted operating income of $731 million, producing an adjusted operating margin of 12.8%. Adjusted net income was $0.60 per diluted share. Chairman, President and CEO Jeff Miller said revenue exceeded the company's expectations and that management took "important steps" toward improving margins. The company repurchased
Halliburton receives a buy rating, driven by its international growth prospects and energy infrastructure opportunities, despite neutral earnings. HAL's Q1 revenues were flat year-over-year, with North America down 5% and the Middle East/Asia up 8%, but still delivered a $125 million revenue surprise. Adjusted EBITDA rose to $1 billion, and operating margin improved to 10.9%, supporting a 17-cent dividend and an attractive, though slightly rich, 17.5x GAAP PE.
Halliburton Co. (NYSE:HAL) on Tuesday reported better-than-expected third-quarter earnings and revenue.
International revenue rose 3% year over year to $3.5 billion. Halliburton repurchased $250 million of common stock in the third quarter.
Halliburton TodayHALHalliburton$33.58 +0.60 (+1.83%) As of 01:50 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$24.12▼$43.59Dividend Yield2.02%P/E Ratio17.59Price Target$44.05Add to WatchlistThe worst takeaway from Halliburton's NYSE: HAL Q3 report was weaker free cash flow alongside higher capital expenditures (CapEx) and its impact on free cash flow (FCF).
Hasbro (HAS), Haliburton (HAL), and Northrop Grumman (NOC) are all charging higher after upbeat earnings reports
Halliburton's international expansion, deepwater contracts and improving margins support its growth outlook despite persistent North American challenges.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Oct 20, 2026 | 0.59 | 0.60 | Beat 2.6% | $5.70B |
| Jul 21, 2026 | 0.54 | 0.55 | Beat 2.2% | $5.71B |
| Apr 21, 2026 | 0.50 | 0.55 | Beat 10.3% | $5.40B |
| Jan 21, 2026 | 0.55 | 0.69 | Beat 25.2% | $5.66B |
| Oct 21, 2025 | 0.50 | 0.58 | Beat 16.3% | $5.60B |
| Jul 22, 2025 | 0.55 | 0.55 | Miss -0.4% | $5.51B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 10-Q | Oct 23, 2026 | 2026-10-23 10:58:22 | View |
| 3 | Oct 20, 2026 | 2026-10-20 15:41:02 | View |
| 8-K | Oct 20, 2026 | 2026-10-20 06:50:56 | View |
| 8-K | Oct 15, 2026 | 2026-10-15 16:20:36 | View |
| 4 | Sep 30, 2026 | 2026-09-30 17:12:29 | View |
| SD | Sep 28, 2026 | 2026-09-28 16:49:38 | View |
| 8-K | Sep 16, 2026 | 2026-09-16 16:05:18 | View |
| 4 | Sep 1, 2026 | 2026-09-01 15:46:19 | View |
| 4 | Aug 20, 2026 | 2026-08-20 16:52:42 | View |
| 4 | Aug 19, 2026 | 2026-08-19 15:21:08 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | HAL | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 14.6x | 15.5x · sector 14.8x | In line |
| Forward P/E (FY26E) | 15.0x | EPS est. 2.33 | In line |
| Price / Book | 2.6x | 3.1x | Discount |
| Price / Sales | 1.3x | 1.3x | In line |
| EV / EBITDA | 8.8x | 8.4x | In line |
| Return on equity | 18.4% | — | Healthy |
| Gross margin | 15.0% | 16.5% | In line |
| Debt / Equity | 0.74 | 1.04 | Moderate |
| Piotroski / Altman Z | 8/9 | Z 3.53 | Safe zone |
Discounted cash flow model
Current price $34.90
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 22, 26 | UBS | maintain | Neutral | Neutral |
| Oct 22, 26 | Freedom Broker | upgrade | Hold | Buy |
| Oct 21, 26 | Jefferies | maintain | Buy | Buy |
| Oct 21, 26 | RBC Capital | maintain | Outperform | Outperform |
| Oct 21, 26 | Barclays | maintain | Overweight | Overweight |
| Oct 19, 26 | Piper Sandler | maintain | Overweight | Overweight |
| Sep 14, 26 | UBS | maintain | Neutral | Neutral |
| Jul 27, 26 | UBS | maintain | Neutral | Neutral |
| Jul 23, 26 | Argus Research | maintain | Buy | Buy |